CBS and Dravet syndrome: Based on the preclinical evidence overviewed in the prior sections, pharmacological inhibition of CBS, the enzyme responsible for the overproduction of H2S, represents a preclinically validated strategy for ameliorating neurocognitive deficits in the young-adult to adult period of DS.